Skip to main content
. 2017 Nov 24;7:16278. doi: 10.1038/s41598-017-16446-7

Figure 6.

Figure 6

The antiviral effects of ICAC against EV71 were disrupted by BSO administration. Infected (100 TCID50 of EV71) Vero cells, treated with 100 µM ICAC, exposed to various concentrations of BSO (0~500 µM). Uninfected cells were used as the control group. Vero cells infected with 100 TCID50 of EV71 alone were used as the model group. Cell viability was detected using the MTS cell proliferation assay kit at 48 hpi. The viability of the control group was set as 100% (n = 6). Asterisks indicate that the data significantly differ from the ICAC group at the P < 0.05 level according to one-way analysis of variance.